Ebselen affects calcium homeostasis in human platelets.

Area of Science:

• Pharmacology
• Cell Biology
• Inflammation Research

Background:

• Ebselen (2-phenyl-1,2-benzoisoselenazol-3-(2H)-one) is a selenoorganic compound with known anti-inflammatory properties.
• Its anti-inflammatory action is primarily attributed to peroxidase activity, potentially reducing peroxide levels that activate inflammatory enzymes.

Purpose of the Study:

• To investigate the effect of ebselen on intracellular calcium homeostasis in human platelets.
• To elucidate the specific mechanisms by which ebselen influences calcium signaling pathways.

Main Methods:

• Experiments were conducted on aspirin-treated human platelets.
• Manganese (Mn2+) influx was used to quench fura-2 fluorescence, assessing extracellular calcium influx.
• Whole-cell patch-clamp and isolated platelet microsomal vesicle experiments were performed to study inositol 1,4,5-trisphosphate (IP3)-induced calcium release.

Main Results:

• Ebselen inhibits agonist-triggered increases in intracellular calcium.
• The compound does not inhibit extracellular calcium influx via receptor-operated calcium channels.
• Ebselen inhibits IP3-induced calcium release from platelet microsomal vesicles.
• Higher concentrations of ebselen (≥ 5 microM) induced calcium release from vesicles, which was reversible by dithiothreitol.

Conclusions:

• Ebselen directly affects intracellular calcium homeostasis by inhibiting calcium release, independent of its peroxidase activity.
• This inhibition of calcium movements may represent a previously unidentified anti-inflammatory mechanism of ebselen.
• Ebselen's direct impact on cellular calcium signaling offers new insights into its therapeutic potential for inflammatory conditions.